KQ Labs’ Post

Our Spirit is getting to the Future First At RYSE, join us in shaping the future of healthcare in an era where the pace of innovation is only accelerating. Shabir Chowdhary, Managing Partner, is at the helm guiding us towards a healthier future. His forward-thinking leadership is steering the Special Opportunities Fund to not only meet but anticipate the growing demand for advanced healthcare solutions. With Shabir's strategic vision, RYSE is not just part of the conversation — we're leading it, ensuring that groundbreaking digital health innovations reach the market faster and more efficiently. By investing in the right people and the right ideas, Shabir is propelling us to the forefront of healthcare evolution. Shabir Chowdhary, Dr. John Lee Allen, Vivien de Tusch-Lec, David Seemungal, Laila Samady-Mustad, PhD, Everett Kamin, Annalisa Jenkins, David Holbrook, Fergus Hay, Eric Kostegan, John Pennant, Chris Turner, Louise Glanvill MD MBA, Andreas Hadjinicolaou, MD, PhD, Dr. Alexander A. Azizi, Heejung Koo, Chris Sawyer, Aleksandar Petrović, Ben Maddison #healthcare #health #innovation #entreprenuership #technology #digitalhealth #business #startups #venturecapital #lifesciences #colloboration #fundraising #AI #ethics #deeptech #RYSE DigitalHealth.London, Novartis, Medtronic, NHS, UK Business Angels Association, British Private Equity & Venture Capital Association (BVCA)

Apply now to get the support you need as a data-driven health start-up: https://t.ly/ax33L At KQ Labs, we understand the unique challenges early-stage start-ups face when using data to innovate in healthcare. That’s why we tailor our support to help founders in this field overcome these obstacles. Our accelerator programme covers topics like accessing health data, protecting proprietary datasets, clinical evidence requirements, and intellectual property, alongside broader essentials such as fundraising and team building. We bring in experts from academia, healthcare, venture capital and beyond to provide valuable insights to our founders. Our tailored approach goes beyond structured workshop sessions. We are committed to the success of each founder, both during the programme and beyond. We take the time to get to know our founders and their unique needs to provide targeted support, ranging from in-house guidance to strategic introductions to experts in our extensive network. We’re here to help you grow. Learn more on our website: https://t.ly/hWKhF Proudly part of The Francis Crick Institute, with sponsorship from Cancer Research Horizons for one cancer-focused venture. #healthtech #techbio #accelerator #datadriven

One lesser-known aspect in the healthcare industry is the growing importance of virtual reality (VR) technology in various healthcare applications. Here are some lesser-known points about VR in healthcare: 1. Therapeutic Applications: VR is increasingly used for therapeutic purposes, such as pain management, phobia treatment, and stress reduction. It provides immersive experiences that can distract patients from pain during medical procedures or help them confront and overcome fears in a controlled environment. 2. Medical Training: VR simulations offer a safe and realistic environment for medical professionals to practice complex procedures without risking patient safety. Surgeons can rehearse surgeries, medical students can explore anatomy in three dimensions, and emergency responders can train for high-stress situations. 3. Mental Health Treatment: VR therapy is emerging as a promising tool for treating various mental health conditions, including PTSD, anxiety disorders, and depression. It allows therapists to create customized environments tailored to each patient's needs, facilitating exposure therapy and cognitive-behavioral interventions. 4. Rehabilitation and Physical Therapy: VR-based rehabilitation programs are being developed to aid in motor recovery after injuries or surgeries. These programs provide interactive exercises and games designed to improve mobility, coordination, and strength in a more engaging and motivating way than traditional therapy methods. 5. Patient Education: VR can enhance patient education by offering immersive experiences that help individuals better understand their medical conditions, treatment options, and the consequences of lifestyle choices. Patients can explore virtual representations of their anatomy, medical procedures, and disease processes, leading to improved health literacy and treatment adherence. 6. Remote Consultations and Telemedicine: VR technology enables immersive telepresence, allowing healthcare providers to conduct remote consultations with patients in different locations. This capability is especially valuable in telemedicine, where doctors can virtually visit patients at home or in remote areas, enhancing access to healthcare services.

I was recently reading a summary of a keynote presentation that was given by Christoph Ruedig and Molly Gilmartin from AlbionVC at the Frontiers Health conference. I was interested to learn that, in a 2023 review of the European healthcare ecosystem, 998 companies were identified across digital pharma 💊 and digital care 🌡️ When compared to the market map for 2022, this year alone there has been a 37% growth in the number of digital care startups and a 50% growth in the number of digital pharma startups. 🩺I wonder if we will continue to see this sort of growth in the wake of the Covid-19 pandemic in 2024 or if growth will start to slow as the world moves onto other crises. Read the full article here: https://loom.ly/cbwQgJs #EuropeanHealthTech #HealthTechPatents #MedTechIP

👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 30th 💥! 🌟This 12-week program is aimed at #Angel to #seriesA stage healthcare companies looking to take their idea beyond concept to investor ready. The course includes:   - How to negotiate on a term sheet - Tech transfer/licensing - Create the right board of directors - Clinical trial design - Manufacturing & contract development - FDA approval process and strategy - Pitching to VC and deck optimization - Intellectual property strategy - Healthcare reimbursement - How to develop revenue strategy 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 30th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE 💎 Meet our workshop speakers: Robert E. "Bob" Sweeney, Max Shapiro, Ernie Riddle, Reza Ghafoorian, MD, Esq., Joshua Goldberg, Shawn Flynn, Sale Kwon, 崔粲, Sheetal Nariani, Isabelle Finger, Lin S., Darwin Ling, Ruming Liu, Faye Karnavy Sahai, Xiaoban Xin, Ling Loerchner, MBA, ICD.D, Scott Lyama and others. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales #marketing #seed #angel #workshop

👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 30th 💥! 🌟This 12-week program is aimed at #Angel to #seriesA stage healthcare companies looking to take their idea beyond concept to investor ready. The course includes:   - How to negotiate on a term sheet - Tech transfer/licensing - Create the right board of directors - Clinical trial design - Manufacturing & contract development - FDA approval process and strategy - Pitching to VC and deck optimization - Intellectual property strategy - Healthcare reimbursement - How to develop revenue strategy 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 30th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE 💎 Meet our workshop speakers: Robert E. "Bob" Sweeney, Max Shapiro, Ernie Riddle, Reza Ghafoorian, MD, Esq., Joshua Goldberg, Shawn Flynn, Sale Kwon, 崔粲, Sheetal Nariani, Isabelle Finger, Lin S., Darwin Ling, Ruming Liu, Faye Karnavy Sahai, Xiaoban Xin, Ling Loerchner, MBA, ICD.D, Scott Lyama and others. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales #marketing #seed #angel #workshop

LA Venture Voices panelist spotlight ✨ Debbie Lin, PhD is an expert in new business model strategy, business development, venture capital in healthcare and medtech with a focus on scientific product development, value proposition refinement, and market access. As Executive Director for Boehringer Ingelheim Venture Fund, Debbie was accountable for digital health investments, board directorship and digital health strategy setting in North America. Prior to her role at the Venture Fund, she was Global Director of Corporate Development where she crafted new business models for healthcare in major global markets. She also supported more than 5 drug launches and a variety of disease indications. 👏 Hear from Debbie Lin, PhD and our other panelists, including CEO & Co-Founder of BRT Biotechnologies, Inc., Jane Liu, Managing General Partner from Propel Bio Partners, Leen Kawas,  and CEO & Founder of Synedgen, Inc, Shenda Baker during a discussion about startup growth and investment in Los Angeles, moderated by the President and Chief Executive Officer at Xencor, Bassil Dahiyat and hosted by HMRI - Huntington Medical Research Institutes! You can register by scanning the QR code in the flyer below or by visiting this link: https://lnkd.in/gUa7yuGN Interested in joining Women In Bio? You can learn more about WIB membership and gain access to our video library, mentorship opportunities, and more here: https://lnkd.in/eSDv3Tsd #LifeSciencesLA #BiotechLA #HealthTechLA #WomenInSTEM #Networking #WomenInLifeSciences #WomenInBiotech #WomenInPharma #WomenInResearch #WomenInBio #WomenInBioLosAngeles #WIB #WIBLA #VentureCapital #LifeSciencesInvesting

Today we’re launching the VentureBlick Super Innovator Search to find and support the next batch of game-changing healthcare innovations! 🔍   From now till 6 August 2024, healthcare startups can apply for the chance to:   🌟 Win non-dilutive prizes valued at US$100,000, including practical support such market validation, mentorship, Europe market access support, and a chance to raise funds with VentureBlick’s global investor network.   🌟 Showcase their innovations to the global healthcare community, potentially opening doors to countless opportunities.   I must caution that this is not for everyone.   The VentureBlick Super Innovator Search is only for promising innovations at proof-of-concept stage or beyond, within these sectors: ⚕️ Medtech 📱 Digital Health 🧫 Biotech or life sciences   Join the Super Innovator Search by 6 August 👉 https://lnkd.in/gEddQ6P7   #SuperInnovatorSearch Dr. Stephan Binder Kalms Consulting JLK Technology Scott Ng Igor Sokół

Cardihab has been chosen to participate in the Brisbane Economic Development Agency (BEDA) MedTech accelerator program. 🎉 🙌 Aimed at fast-tracking global investment and market entry for local #MedTech organisations, the program is designed to connect startup or early-stage innovation companies with international capital funders and strategic partners.   Delivered in partnership with US based investment facilitator Life Science Nation, the BEDA MedTech accelerator cohort companies are invited to attend the global investor RESI Conference in San Francisco where they will pitch to active investors during JP Morgan Healthcare Week early next year. Cardihab is committed to transformational change in the way that #cardiacrehabilitation is equitably accessed and experienced for patients and clinicians, with the aim of impacting poor rates of participation and correlated #healthoutcomes.   “We know there is significant need for a high quality, clinically validated solution like Cardihab, particularly in the US where the current cost of poor health outcomes for those with heart disease is in the vicinity of $1 billion per day,” says Cardihab CEO Helen Souris.    “We’re very happy to have been awarded the opportunity by BEDA to participate in this accelerator program, and the opportunity to meet with partners who can provide a pathway into these markets where the need for quality healthcare solutions is significant.”     Lord Mayor Adrian Schrinner says, “Brisbane is at the forefront of medical technology innovation globally and this year’s cohort represent the next wave of groundbreaking health solutions.”     “We are proud to support these businesses as they continue to innovate and make a positive impact on healthcare worldwide.”    Read more about the program 👉 👉 https://lnkd.in/gD3dwtV5 #accelerator #investors #brisbane #healthtech #innovation #DTx #choosebrisbane #alivewithopportunity George Lambrou Alanna DeGraaf Christine Kwong RN CHIA Caroline White Philip Barnes John Rivers Tim Fortin Hugh Dawkins Paul Butler ANDHealth

Thinking about relocating your wound care startup to Europe? The EWMA Innovation Alliance (EIA) is here to support startups outside of Europe interested in making the move. EIA offers to help you succeed, including:  🔹 Insights into Europe’s leading wound care competence hubs  🔹 Connections with top European Key Opinion Leaders  🔹 Information on clinical trial sites across the continent  🔹 Promotion within the European wound management ecosystem  🔹 Discounts on EIA services  🔹 Organizing partnership conferences together with your home university Ready to take the next step? Learn more about how EIA can assist you on your journey https://lnkd.in/dE-Wr-UE #WoundCare #HealthcareInnovation #EWMAInnovationAlliance #StartupRelocation #MedTech #Pharma #EuropeanMarket #HealthcareEcosystem #ClinicalTrials #HealthTechStartups #InnovationHub #HealthcarePartnerships #RelocateToEurope #HealthcareEntrepreneurs